TENAX THERAPEUTICS, INC. Accrued Investment Income Receivable
TENAX THERAPEUTICS, INC. (TENX) had Accrued Investment Income Receivable of $4.69 thousand as of 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Balance Sheet › Assets
us-gaap:AccruedInvestmentIncomeReceivable · last filed 2021-08-16
- 2021-06-30: Accrued Investment Income Receivable $4.69K.
- 2021-03-31: Accrued Investment Income Receivable $3.36K.
- 2020-12-31: Accrued Investment Income Receivable $3.55K.
- 2020-09-30: Accrued Investment Income Receivable $3.24K.
| Period end | Accrued Investment Income Receivable |
|---|---|
| 2021-06-30 | $4.69K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $3.36K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $3.55K 10-K/A · filed 2021-04-16 |
| 2020-09-30 | $3.24K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $3.45K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $3.60K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $2.69K 10-K · filed 2020-03-30 |
| 2019-09-30 | $3.01K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $2.49K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.87K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $2.20K 10-K · filed 2019-04-01 |
| 2015-07-31 | $364.08K 10-Q · filed 2015-09-09 |
| 2015-04-30 | $326.07K 10-K · filed 2015-07-14 |
| 2015-01-31 | $340.38K 10-Q · filed 2015-03-17 |
| 2014-10-31 | $313.85K 10-Q · filed 2014-12-15 |
| 2014-07-31 | $283.37K 10-Q · filed 2014-09-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |